Effect of combined oestrogen-progestogen oral contraceptives, oestrogen, and progestogen on antiplasmin and antithrombin activity

Prevention of fibrinolytic shut-down after major surgery by intramuscular stanozolol.

Thrombosis research·2010

Topoisomerase II alpha and II beta expression in childhood acute lymphoblastic leukaemia: relation to prognostic factors and clinical outcome.

Journal of clinical pathology·2001

Herbal products and conventional medicines used by community-residing older women.

Journal of advanced nursing·2001

Expression of topoisomerase IIIalpha in normal and neoplastic tissues determined by immunohistochemistry using a novel monoclonal antibody.

British journal of cancer·2000

A European view on the North American fifth consensus on antithrombotic therapy.

Chest·2000

Monoclonal antibodies recognizing CD5, CD10 and CD23 in formalin-fixed, paraffin-embedded tissue: production and assessment of their value in the diagnosis of small B-cell lymphoma.

Histopathology·2000

The 2026 report of the Lancet Countdown on health and climate change: a decade of escalating health harms and a decisive moment for all.

Lancet (London, England)·2026

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Lancet (London, England)·2026

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

Lancet (London, England)·2026

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Lancet (London, England)·2026

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

Lancet (London, England)·2026

Accessory Cavitating Uterine Masses/Malformation: An Important Differential in Women With Intractable Dysmenorrhea and Chronic Pelvic Pain Across All Ages.

The journal of obstetrics and gynaecology research·2026

Cytogenetic analysis of couples with recurrent pregnancy loss in taiwan: A retrospective study of 451cases.

Taiwanese journal of obstetrics & gynecology·2026

Efficacy of estetrol (E4) 15 mg/ drospirenone (DRSP) 3 mg combination for the treatment of dysmenorrhea in women with recurrent endometriosis and/or adenomyosis.

Taiwanese journal of obstetrics & gynecology·2026

Evaluation and Management of Syncope in Pregnancy and Postpartum.

Obstetrics and gynecology clinics of North America·2026

Common Arrhythmias in Pregnancy.

Obstetrics and gynecology clinics of North America·2026

Posterior Tibial Tendon Dysfunction in Women: Role of Hormones, Estrogen, Weight Gain, Pregnancy.

Foot and ankle clinics·2026

Effect of combined oestrogen-progestogen oral contraceptives, oestrogen, and progestogen on antiplasmin and antithrombin activity

Related Experiment Videos

Related Concept Videos

Prevention of fibrinolytic shut-down after major surgery by intramuscular stanozolol.

Topoisomerase II alpha and II beta expression in childhood acute lymphoblastic leukaemia: relation to prognostic factors and clinical outcome.

Herbal products and conventional medicines used by community-residing older women.

Expression of topoisomerase IIIalpha in normal and neoplastic tissues determined by immunohistochemistry using a novel monoclonal antibody.

A European view on the North American fifth consensus on antithrombotic therapy.

Monoclonal antibodies recognizing CD5, CD10 and CD23 in formalin-fixed, paraffin-embedded tissue: production and assessment of their value in the diagnosis of small B-cell lymphoma.

The 2026 report of the Lancet Countdown on health and climate change: a decade of escalating health harms and a decisive moment for all.

Izalontamab brengitecan versus platinum-based chemotherapy in EGFR-mutated advanced non-squamous non-small-cell lung cancer after progression on third-generation EGFR tyrosine kinase inhibitors (PANKU-Lung01): a multicentre, randomised, open-label, phase 3 trial in China.

Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial.

Izalontamab brengitecan for HR+/HER2- breast cancer in China (PANKU-Breast01): a randomised, phase 3 trial.

First-line pembrolizumab versus carboplatin plus paclitaxel in participants with mismatch repair-deficient advanced or recurrent endometrial cancer (KEYNOTE-C93/GOG-3064/ENGOT-en15): interim analysis of a multicentre, open-label, randomised, active-comparator controlled, phase 3 trial.

Ruzaltatug rezetecan versus chemotherapy for EGFR-mutated advanced non-small-cell lung cancer progressing after EGFR tyrosine kinase inhibitor therapy (HERON-Lung01): interim analysis of a randomised, open-label, phase 3 trial in China.

Accessory Cavitating Uterine Masses/Malformation: An Important Differential in Women With Intractable Dysmenorrhea and Chronic Pelvic Pain Across All Ages.

Cytogenetic analysis of couples with recurrent pregnancy loss in taiwan: A retrospective study of 451cases.

Efficacy of estetrol (E4) 15 mg/ drospirenone (DRSP) 3 mg combination for the treatment of dysmenorrhea in women with recurrent endometriosis and/or adenomyosis.

Evaluation and Management of Syncope in Pregnancy and Postpartum.

Common Arrhythmias in Pregnancy.

Posterior Tibial Tendon Dysfunction in Women: Role of Hormones, Estrogen, Weight Gain, Pregnancy.

Effect of combined oestrogen-progestogen oral contraceptives, oestrogen, and progestogen on antiplasmin and antithrombin activity

Related Experiment Videos

Related Concept Videos

Related Articles